Analyzing priority challenges in China's vaccine regulation with the Hanlon methodWANG Ri-zhen, XU Ming, PAN Hai-long, ZUO Shu-yan, YUAN Yuan, HUANG Yang-mu673-678
Gastric organoids model reveals the host-pathogen interaction mechanism of Helicobacter pylori infection:from colonization mechanism to targeted therapyTIAN Shu-ting, ZHANG Lin-li, DENG Yi-fang679-687
The introduction and enlightenment of drug price management and the new price review framework in CanadaOU Yang-lu, HU Hong-fei, ZHOU Ting688-694
The complete response letter in FDA's review decision feedback mechanism and its implications for ChinaLU Jian, SHA Ming-quan, DONG Mei-yi, BAI Yu695-700
Research advances in key technologies and real-time quality control for quality by design-driven micrometer-scale tablet formulationsWU Lei, REN Peng-fei, YU Zhou-bo, LI Zhen-bo, HE Yu-xin, LIU Yi-han, YANG Jing, WANG Rui701-709
Current status and considerations on the control of ethylene glycol,diethylene glycol,and triethylene glycol impurities in pharmaceutical excipientsWANG Jue, WANG Xiao-feng, ZHANG Xue-yan, ZHAO Xia, NING Bao-ming, LING Xiao, TU Jia-sheng, YANG Rui, ZHANG Jun, SUN Hui-min710-721
Analysis and standardization strategies of serious adverse event reports in pediatric drug clinical trialsGUO Chun-yan, ZHANG Yi, YANG Yu-xin, LIANG Yu-guang, DING Qian, WANG Qian, ZHANG Meng, SONG Li-juan, ZHANG Cheng-yue, SUN Yu, GUO Peng722-726
Bibliometric analysis of AI technologies applied in drug clinical trials:perspectives from global and Chinese research domainsXIONG Xue-mei, GU Jin, HU Chen-xi, HUANG Yuan-kai, XU Hou-ming727-733
Simultaneous determination of 10 components in Puqin Jiedu Lishi granules by HPLC-PDA methodLI Shuai-yin, XI Hui-rong, CHEN Ting, LI Xi-xiang, LI Xiao-feng, ZHOU Ya-li, YANG Shou-yuan734-740
Exploring the therapeutic effects and underlying mechanisms of Tibetan medicine Xiaoboyuganzi decoction on type 2 diabetes mellitus via network pharmacologyTIAN Mei-gui, ZONG Yi, PENG Jia-yan, HUANG Xue-mei, XIONG Shuang-feng, ZHANG Jing, FAN Gang741-748